Tafasitamab Biosimilar – Research Grade [ICH5132]
$300.00 – $5,000.00
Tafasitamab Biosimilar – Research Grade
ichorbio’s Tafasitamab Biosimilar for Research Use Only (RUO) and not for therapeutic use.
CD19
ichorbio’s Tafasitamab Biosimilar is available in the following sizes:
1mg, 5mg, 10mg, 20mg, 50mg
Human IgG1(S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa
CHO Cells
Human
Uses the same sequence as the therapeutic antibody Tafasitamab
Detects human CD19. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Tafasitamab.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
5mg/ml
Sterile, preservative-free, solution in PBS. BSA and Azide free.
>95% by SDS-PAGE
≤ 1.0 EU/mg as determined by the LAL method
This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Functional Assays
This biosimilar is strictly for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
| Weight | 141 kg |
|---|---|
| Dimensions | 141 × 114 × 141 cm |
| Size: | |
| Endotoxin Level: | Low |
Be the first to review “Tafasitamab Biosimilar – Research Grade [ICH5132]”
Related products
Reviews
There are no reviews yet.